Short‐Term Influence of Radiofrequency Ablation on NT‐proBNP, MR‐proANP, Copeptin, and MR‐proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF Study

Author:

Charitakis Emmanouil1,Walfridsson Håkan1,Alehagen Urban1

Affiliation:

1. Department of Cardiology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden

Abstract

Background There is limited knowledge on the short‐term influence of radiofrequency ablation ( RFA ) of atrial fibrillation ( AF ) on 2 cardiac biomarkers; the N‐terminal pro‐B‐type natriuretic peptide ( NT ‐pro BNP ) and the midregional fragment of the N‐terminal of pro‐ ANP ( MR ‐pro ANP ) and 2 extracardiac biomarkers; the c‐terminal provasopressin (copeptin) and the midregional portion of proadrenomedullin ( MR ‐pro ADM ). There are also limited data concerning cardiac production of the latter two. Methods and Results We studied 192 consecutive patients eligible for RFA of AF referred to the University Hospital, Linköping, Sweden. NT ‐pro BNP , MR ‐pro ANP , copeptin, and MR ‐pro ADM levels were measured in peripheral blood, the coronary sinus ( CS ), and the left atrium before ablation, and in peripheral blood immediately and the day after RFA . The level of NT ‐pro BNP decreased the day after RFA in participants in AF at the time of RFA , compared to the participants in sinus rhythm who showed a slight increase ( P <0.001). Furthermore, regardless of the actual rhythm, the level of MR ‐pro ANP showed an increase immediately after RFA ( P <0.001), followed by a decrease the day after ablation ( P <0.001). Copeptin level showed a 6‐fold increase immediately after RFA compared to baseline ( P <0.001), whereas MR ‐pro ADM level increased the day after RFA ( P <0.001). Levels of copeptin and MR ‐pro ADM were not higher in the CS compared to peripheral blood. Conclusions RFA of AF is a strong stimulus with a significant and direct impact on different neurohormonal systems. We found no sign of a cardiac release of MR ‐pro ADM or copeptin. Clinical Trial Registration URL : http://www.clinicaltrials.gov . Unique Identifier: NCT 01553045.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3